Peter Sebo got a PhD. (CSc.) in microbiology in 1990 in Prague and did his postdoc at Institut Pasteur in Paris (1990-95). Since 1995, he heads a lab at the Institute of Microbiology of the Czech Academy of Sciences (CAS) in Prague. He also founded the Institute of Biotechnology of the CAS and designed the BIOCEV research center in Vestec and also serves as professor of microbiology at the University of Chemistry and Technology in Prague. Peter Sebo's research focuses on bacterial pathogenesis and the mechanisms of Bordetella pertussis virulence and toxin action. Prof.

After completing a PhD in immuno-oncology in 2001 at GIMAP (INSERM), Jean-Philippe Herbeuval was awarded a 5-year Fogarty Fellowship at the NIH (USA) in Dr. G. Shearer's lab to work on the antiviral response to HIV. His work earned him the Norman P. Salzman Award (NIH, FDA, CDC) and the NIH Cash Award in 2005. He was recruited as a CR1 researcher by the CNRS in 2001 at Necker Hospital (UMR8147), where he established a research group.

Prof. L. Zitvogel, MD (Clinical Oncology), PhD (Tumor Immunology), full professor at the University Paris Saclay, graduated in Medical Oncology in 1992. Scientific career first at the University of Pittsburgh, US. Became Research Director at Institut National de la Santé et Recherche Médicale U1015, and Scientific Director of the Clinicobiome program at Gustave Roussy, the largest cancer Center in Europe in 1998. Actively contributed to the field of cancer immunology and immunotherapy.